Intellectual Asset Management Recognizes Foley Attorneys in 2020 Patent 1000 Guide
May 1, 2020
Patent 1000 – The World’s Leading Patent Professionals
Intellectual Asset Management (IAM) has recognized 16 Foley attorneys in the 9th edition of its Patent 1000 – The World’s Leading Patent Professionals guide. Additionally, the firm was recognized for offices and practices, including the District of Columbia (prosecution), Boston (prosecution and litigation) Detroit, Milwaukee and Tokyo (litigation).
The Foley attorneys recognized include:
- Scott Anderson, prosecution
- Courtenay Brinckerhoff, prosecution
- Jeffrey Costakos, litigation
- Etsuo Doi, transactions
- Jeanne Gills, litigation
- Jeffrey Gundersen, prosecution
- John Lanza, prosecution
- Matthew Lowrie, litigation
- Stephen Maebius, post-grant proceedings, prosecution, transactions
- Christopher McKenna, prosecution
- George Quillin, post-grant proceedings, prosecution
- Michele Simkin, prosecution
- Gary Solomon, prosecution
- Eric Sophir, prosecution
-
Marcus Sprow, prosecution
- Joseph Ziebert, prosecution
The Patent 1000 – The World’s Leading Patent Professionals guide is compiled by a team of researchers from IAM magazine based on more than 1,800 interviews with private practice and in-house professionals regarding the full range of patent services.
People
Related News
September 18, 2026
In the News
Patrick Daugherty Authors Article on Navigating Proposed SEC Crypto Asset Regulations
Foley & Lardner LLP partner Patrick Daugherty authored the Columbia Law School’s Blue Sky Blog article, “How to Advise Token Developers in Light of Proposed SEC Regulation Crypto Assets.”
September 17, 2026
In the News
Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®
Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.
September 15, 2026
In the News
David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials
Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.